Image source: shutterstock.com
Parents trust children’s medicines to bring relief, not risk. But even well-known brands can face safety issues leading to product recalls. Over the past few years, several over-the-counter and prescription products have been pulled due to contamination, packaging flaws, or dosage inconsistencies. Knowing which medications were affected and why can help families stay vigilant. Here are ten recent examples of a children’s medication recall that made headlines and prompted families to check their medicine cabinets.
1. Little Remedies Honey Cough Syrup
In mid-2025, Medtech Products recalled multiple lots of Little Remedies Honey Cough Syrup after tests revealed possible microbial contamination. The affected lots were distributed nationwide and may have contained harmful bacteria that could cause illness. Parents were advised to stop using any bottles purchased before June and contact the manufacturer for refunds. While no adverse events were reported, the recall highlighted how even natural, honey-based formulas can face quality control issues. Consumers were reminded to store all cough products in a cool, dry place to maintain stability.
2. Benadryl Liquid Elixir (100 mL)
In March 2025, a recall was issued for a limited number of Benadryl Liquid Elixir bottles due to improper child-resistant packaging. Although the formula itself was safe, the packaging failed federal standards, creating a risk if small children accessed the medicine without supervision. The affected bottles were mainly sold through online retailers and contained identifying lot codes printed on the label base. Parents were encouraged to dispose of the product and contact customer service for reimbursement. This event reinforced the importance of checking both packaging and expiration dates for all liquid medications.
3. Safetussin Max Strength Multi-Symptom Caplets
Another notable children’s medication recall occurred in April 2025 involving Safetussin Max Strength Multi-Symptom Cough, Cold & Flu Caplets. The issue stemmed from blister pack designs that failed to meet child safety requirements, allowing easier access to the medicine. Although the tablets themselves were safe when used correctly, the packaging posed an accidental ingestion risk. Parents were urged to store any remaining products out of reach and return them for a refund. The recall served as a reminder that design flaws can be just as dangerous as formulation errors.
4. Sulfamethoxazole/Trimethoprim Tablets 400/80 mg
Amneal Pharmaceuticals recalled several lots of this commonly prescribed antibiotic, often used for pediatric infections, due to potential contamination concerns. The affected tablets may have contained impurities that could compromise treatment effectiveness or trigger unwanted reactions. Pharmacies were directed to remove all impacted stock from their shelves. Parents were advised to confirm lot numbers with their pharmacist and seek replacement prescriptions if necessary. This children’s medication recall underscored how even widely trusted antibiotics must undergo ongoing safety checks.
5. Medline Neonatal & Pediatric Intubation Kits
Though technically a device recall, this case affected products used in pediatric care. Medline Industries recalled neonatal and pediatric intubation kits after discovering that some tubes were smaller in diameter than labeled. This posed a serious risk of inadequate ventilation for infants and young children. Hospitals were advised to check inventory and return any affected kits immediately. The incident reinforced the importance of rigorous testing for all tools used in children’s medical procedures.
6. G-Supress DX Pediatric Drops
In 2022, a Class I recall was issued for G-Supress DX Pediatric Drops due to a formulation mix-up. This labeling error meant the medication inside didn’t match what was printed on the packaging, creating a serious safety risk for children. Class I recalls are the most urgent category, issued when a product could cause severe harm or death. Pharmacies removed the affected lots, and families were advised to stop use immediately. The event reminded consumers that even minor label errors can have major health implications.
7. KinderMed Kids & Infants Pain & Fever
KinderMed voluntarily recalled its Kids and Infants Pain & Fever formulas after discovering instability in the acetaminophen ingredient. Over time, the medication’s potency could shift, leading to inconsistent dosing. That meant a child could receive either too little relief or too much acetaminophen, increasing the risk of liver damage. The company offered refunds and advised parents to contact healthcare providers if symptoms persisted. This children’s medication recall showed that ingredient stability can be just as critical as contamination control.
8. Zicam Cold Remedy and Orajel Baby Teething Swabs
Church & Dwight announced a nationwide recall of Zicam Cold Remedy Nasal Swabs, Zicam AllClear Swabs, and Orajel Baby Teething Swabs due to microbial contamination. The contamination risk came from fungal growth in the cotton applicators, which could cause infections in children with weakened immune systems. Parents were instructed to stop use and request reimbursement. No illnesses were reported, but the voluntary recall was issued out of caution. The case highlighted how even topical or nasal products can pose unseen risks when hygiene standards slip.
9. McNeil’s Children’s and Infant Liquid Medicines
McNeil Consumer Healthcare, known for brands like Tylenol and Motrin, initiated a large recall in 2025 affecting several children’s liquid medications. Manufacturing inconsistencies led to varying concentrations of active ingredients, raising concerns about potential overdosing or reduced efficacy. The company quickly halted distribution and removed affected lots from shelves nationwide. Consumers were urged to review lot codes and stop using the products until replacements were issued. This recall served as a reminder that trusted household names can still face unexpected safety challenges.
10. Ingestible Fluoride Prescription Products
In 2025, the FDA began removing unapproved ingestible fluoride prescription products marketed for children. These unregulated items had never undergone formal safety reviews but were being sold for pediatric dental protection. The FDA warned that these products could expose children to unsafe fluoride levels if swallowed regularly. Health professionals were instructed to stop prescribing or distributing the affected items immediately. This move emphasized the government’s growing scrutiny over products that blur the line between supplements and medications.
Keeping Your Family Safe from the Next Recall
Every children’s medication recall underscores how crucial it is for families to stay informed. Parents can sign up for FDA recall alerts, regularly inspect medicine labels, and safely dispose of any expired or recalled products. It’s also wise to consult a pharmacist before using lesser-known brands or online-only medicines. Small steps like these can prevent serious harm and ensure every product in your cabinet is safe. Staying proactive turns recall awareness into protection for your child’s health.
Do you routinely check your medicine cabinet for recalled or expired products? Share how you stay informed in the comments below!
What to Read Next…
8 Medical Bills Related to Children That Insurance Rarely Covers
The Unexpected Cost: 11 Unexpected Medical Bills That Bankrupt New Parents
Beyond The Label: 8 Medication Combinations Dangerous For Kids
Medical Update: 6 Urgent Updates to Your Child’s Medical History
Dangerous Mix: 8 Medications With Dangerous Side Effects in Kids
The post 10 Children’s Medications That Were Recently Recalled appeared first on Kids Ain't Cheap.
